APO RESEARCH · REPORT
Remifentanil Hydrochloride
Remifentanil Hydrochloride (also named Ultiva) is a kind of white to off-white crystalline powder or crystals that used to maintain analgesia and anesthesia induction of general anesthesia. Remifentanil Hydrochloride is freely soluble in water, sparingly soluble in ethanol, slightly soluble in isopropyl alcohol and very slightly soluble in methyl isobutyl ketone.
Product & engineering
Understand the product.
Remifentanil Hydrochloride (also named Ultiva) is a kind of white to off-white crystalline powder or crystals that used to maintain analgesia and anesthesia induction of general anesthesia. Remifentanil Hydrochloride is freely soluble in water, sparingly soluble in ethanol, slightly soluble in isopropyl alcohol and very slightly soluble in methyl isobutyl ketone.
Remifentanil Hydrochloride should be administered only in a setting fully equipped for the monitoring and support of respiratory and cardiovascular function and by persons specifically trained in the use of anaesthetic drugs and the recognition and management of the expected adverse effects of potent opioids, including respiratory and cardiac resuscitation. Such training must include the establishment and maintenance of a patent airway and assisted ventilation.
Selected research
Market Analysis & Forecast
Global Remifentanil Hydrochloride Market Analysis and Forecast 2026-2032
Market perspective
Remifentanil Hydrochloride (also named Ultiva) is a kind of white to off-white crystalline powder or crystals that used to maintain analgesia and anesthesia induction of general anesthesia. Remifentanil Hydrochloride is freely soluble in water, sparingly soluble in ethanol, slightly soluble in isopropyl alcohol and very slightly soluble in methyl isobutyl ketone.
Remifentanil Hydrochloride should be administered only in a setting fully equipped for the monitoring and support of respiratory and cardiovascular function and by persons specifically trained in the use of anaesthetic drugs and the recognition and management of the expected adverse effects of potent opioids, including respiratory and cardiac resuscitation. Such training must include the establishment and maintenance of a patent airway and assisted ventilation.
In Europe, Remifentanil Hydrochloride key players include GSK, Macfarlan Smith, Abbott, Mylan, Arevipharma, etc. The top five players hold a share about 85%.
Read the full market overview
UK is the largest market, with a share about 20%, followed by Germany and France, having a total share about 30 percent.
In terms of product, 1mg/Pcs is the largest segment, with a share about 85%. And in terms of application, the largest application is Endotracheal Intubation Operation, followed by Neurosurgery, Outpatient Surgery, Postoperative Analgesia, etc.
This report presents an overview of global market for Remifentanil Hydrochloride, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Remifentanil Hydrochloride, also provides the sales of main regions and countries. Of the upcoming market potential for Remifentanil Hydrochloride, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Remifentanil Hydrochloride sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Remifentanil Hydrochloride market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Remifentanil Hydrochloride sales, projected growth trends, production technology, application and end-user industry.
Remifentanil Hydrochloride Segment by Company
GSK
Macfarlan Smith
Abbott
Mylan
Arevipharma
AMRI
Remifentanil Hydrochloride Segment by Type
1mg/Pcs
2mg/Pcs
5mg/Pcs
Remifentanil Hydrochloride Segment by Application
Endotracheal Intubation Operation
Neurosurgery
Outpatient Surgery
Postoperative Analgesia
Other
Remifentanil Hydrochloride Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Remifentanil Hydrochloride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Remifentanil Hydrochloride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Remifentanil Hydrochloride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Remifentanil Hydrochloride in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Remifentanil Hydrochloride manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Remifentanil Hydrochloride sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1mg/Pcs
- 2mg/Pcs
- 5mg/Pcs
Applications
- Endotracheal Intubation Operation
- Neurosurgery
- Outpatient Surgery
- Postoperative Analgesia
- Other
Companies covered
- GSK
- Macfarlan Smith
- Abbott
- Mylan
- Arevipharma
- AMRI
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Remifentanil Hydrochloride Market by Type
- 1.2.1 Global Remifentanil Hydrochloride Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 1mg/Pcs
- 1.2.3 2mg/Pcs
- 1.2.4 5mg/Pcs
- 1.3 Remifentanil Hydrochloride Market by Application
- 1.3.1 Global Remifentanil Hydrochloride Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Endotracheal Intubation Operation
- 1.3.3 Neurosurgery
- 1.3.4 Outpatient Surgery
- 1.3.5 Postoperative Analgesia
- 1.3.6 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Remifentanil Hydrochloride Market Dynamics
- 2.1 Remifentanil Hydrochloride Industry Trends
- 2.2 Remifentanil Hydrochloride Industry Drivers
- 2.3 Remifentanil Hydrochloride Industry Opportunities and Challenges
- 2.4 Remifentanil Hydrochloride Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Remifentanil Hydrochloride Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Remifentanil Hydrochloride Revenue by Region
- 3.2.1 Global Remifentanil Hydrochloride Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Remifentanil Hydrochloride Revenue by Region (2021-2026)
- 3.2.3 Global Remifentanil Hydrochloride Revenue by Region (2027-2032)
- 3.2.4 Global Remifentanil Hydrochloride Revenue Market Share by Region (2021-2032)
- 3.3 Global Remifentanil Hydrochloride Sales Estimates and Forecasts 2021-2032
- 3.4 Global Remifentanil Hydrochloride Sales by Region
- 3.4.1 Global Remifentanil Hydrochloride Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Remifentanil Hydrochloride Sales by Region (2021-2026)
- 3.4.3 Global Remifentanil Hydrochloride Sales by Region (2027-2032)
- 3.4.4 Global Remifentanil Hydrochloride Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Remifentanil Hydrochloride Revenue by Manufacturers
- 4.1.1 Global Remifentanil Hydrochloride Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Remifentanil Hydrochloride Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Remifentanil Hydrochloride Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Remifentanil Hydrochloride Sales by Manufacturers
- 4.2.1 Global Remifentanil Hydrochloride Sales by Manufacturers (2021-2026)
- 4.2.2 Global Remifentanil Hydrochloride Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Remifentanil Hydrochloride Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Remifentanil Hydrochloride Sales Price by Manufacturers (2021-2026)
- 4.4 Global Remifentanil Hydrochloride Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Remifentanil Hydrochloride Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Remifentanil Hydrochloride Manufacturers, Product Type & Application
- 4.7 Global Remifentanil Hydrochloride Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Remifentanil Hydrochloride Market CR5 and HHI
- 4.8.2 2025 Remifentanil Hydrochloride Tier 1, Tier 2, and Tier 3
5 Remifentanil Hydrochloride Market by Type
- 5.1 Global Remifentanil Hydrochloride Revenue by Type
- 5.1.1 Global Remifentanil Hydrochloride Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Remifentanil Hydrochloride Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Remifentanil Hydrochloride Revenue Market Share by Type (2021-2032)
- 5.2 Global Remifentanil Hydrochloride Sales by Type
- 5.2.1 Global Remifentanil Hydrochloride Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Remifentanil Hydrochloride Sales by Type (2021-2032) & (K Pcs)
- 5.2.3 Global Remifentanil Hydrochloride Sales Market Share by Type (2021-2032)
- 5.3 Global Remifentanil Hydrochloride Price by Type
6 Remifentanil Hydrochloride Market by Application
- 6.1 Global Remifentanil Hydrochloride Revenue by Application
- 6.1.1 Global Remifentanil Hydrochloride Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Remifentanil Hydrochloride Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Remifentanil Hydrochloride Revenue Market Share by Application (2021-2032)
- 6.2 Global Remifentanil Hydrochloride Sales by Application
- 6.2.1 Global Remifentanil Hydrochloride Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Remifentanil Hydrochloride Sales by Application (2021-2032) & (K Pcs)
- 6.2.3 Global Remifentanil Hydrochloride Sales Market Share by Application (2021-2032)
- 6.3 Global Remifentanil Hydrochloride Price by Application
7 Company Profiles
- 7.1 GSK
- 7.1.1 GSK Company Information
- 7.1.2 GSK Business Overview
- 7.1.3 GSK Remifentanil Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 GSK Remifentanil Hydrochloride Product Portfolio
- 7.1.5 GSK Recent Developments
- 7.2 Macfarlan Smith
- 7.2.1 Macfarlan Smith Company Information
- 7.2.2 Macfarlan Smith Business Overview
- 7.2.3 Macfarlan Smith Remifentanil Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Macfarlan Smith Remifentanil Hydrochloride Product Portfolio
- 7.2.5 Macfarlan Smith Recent Developments
- 7.3 Abbott
- 7.3.1 Abbott Company Information
- 7.3.2 Abbott Business Overview
- 7.3.3 Abbott Remifentanil Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Abbott Remifentanil Hydrochloride Product Portfolio
- 7.3.5 Abbott Recent Developments
- 7.4 Mylan
- 7.4.1 Mylan Company Information
- 7.4.2 Mylan Business Overview
- 7.4.3 Mylan Remifentanil Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Mylan Remifentanil Hydrochloride Product Portfolio
- 7.4.5 Mylan Recent Developments
- 7.5 Arevipharma
- 7.5.1 Arevipharma Company Information
- 7.5.2 Arevipharma Business Overview
- 7.5.3 Arevipharma Remifentanil Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Arevipharma Remifentanil Hydrochloride Product Portfolio
- 7.5.5 Arevipharma Recent Developments
- 7.6 AMRI
- 7.6.1 AMRI Company Information
- 7.6.2 AMRI Business Overview
- 7.6.3 AMRI Remifentanil Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 AMRI Remifentanil Hydrochloride Product Portfolio
- 7.6.5 AMRI Recent Developments
8 North America
- 8.1 North America Remifentanil Hydrochloride Market Size by Type
- 8.1.1 North America Remifentanil Hydrochloride Revenue by Type (2021-2032)
- 8.1.2 North America Remifentanil Hydrochloride Sales by Type (2021-2032)
- 8.1.3 North America Remifentanil Hydrochloride Price by Type (2021-2032)
- 8.2 North America Remifentanil Hydrochloride Market Size by Application
- 8.2.1 North America Remifentanil Hydrochloride Revenue by Application (2021-2032)
- 8.2.2 North America Remifentanil Hydrochloride Sales by Application (2021-2032)
- 8.2.3 North America Remifentanil Hydrochloride Price by Application (2021-2032)
- 8.3 North America Remifentanil Hydrochloride Market Size by Country
- 8.3.1 North America Remifentanil Hydrochloride Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Remifentanil Hydrochloride Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Remifentanil Hydrochloride Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Remifentanil Hydrochloride Market Size by Type
- 9.1.1 Europe Remifentanil Hydrochloride Revenue by Type (2021-2032)
- 9.1.2 Europe Remifentanil Hydrochloride Sales by Type (2021-2032)
- 9.1.3 Europe Remifentanil Hydrochloride Price by Type (2021-2032)
- 9.2 Europe Remifentanil Hydrochloride Market Size by Application
- 9.2.1 Europe Remifentanil Hydrochloride Revenue by Application (2021-2032)
- 9.2.2 Europe Remifentanil Hydrochloride Sales by Application (2021-2032)
- 9.2.3 Europe Remifentanil Hydrochloride Price by Application (2021-2032)
- 9.3 Europe Remifentanil Hydrochloride Market Size by Country
- 9.3.1 Europe Remifentanil Hydrochloride Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Remifentanil Hydrochloride Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Remifentanil Hydrochloride Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Remifentanil Hydrochloride Market Size by Type
- 10.1.1 China Remifentanil Hydrochloride Revenue by Type (2021-2032)
- 10.1.2 China Remifentanil Hydrochloride Sales by Type (2021-2032)
- 10.1.3 China Remifentanil Hydrochloride Price by Type (2021-2032)
- 10.2 China Remifentanil Hydrochloride Market Size by Application
- 10.2.1 China Remifentanil Hydrochloride Revenue by Application (2021-2032)
- 10.2.2 China Remifentanil Hydrochloride Sales by Application (2021-2032)
- 10.2.3 China Remifentanil Hydrochloride Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Remifentanil Hydrochloride Market Size by Type
- 11.1.1 Asia Remifentanil Hydrochloride Revenue by Type (2021-2032)
- 11.1.2 Asia Remifentanil Hydrochloride Sales by Type (2021-2032)
- 11.1.3 Asia Remifentanil Hydrochloride Price by Type (2021-2032)
- 11.2 Asia Remifentanil Hydrochloride Market Size by Application
- 11.2.1 Asia Remifentanil Hydrochloride Revenue by Application (2021-2032)
- 11.2.2 Asia Remifentanil Hydrochloride Sales by Application (2021-2032)
- 11.2.3 Asia Remifentanil Hydrochloride Price by Application (2021-2032)
- 11.3 Asia Remifentanil Hydrochloride Market Size by Country
- 11.3.1 Asia Remifentanil Hydrochloride Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Remifentanil Hydrochloride Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Remifentanil Hydrochloride Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Remifentanil Hydrochloride Market Size by Type
- 12.1.1 SAMEA Remifentanil Hydrochloride Revenue by Type (2021-2032)
- 12.1.2 SAMEA Remifentanil Hydrochloride Sales by Type (2021-2032)
- 12.1.3 SAMEA Remifentanil Hydrochloride Price by Type (2021-2032)
- 12.2 SAMEA Remifentanil Hydrochloride Market Size by Application
- 12.2.1 SAMEA Remifentanil Hydrochloride Revenue by Application (2021-2032)
- 12.2.2 SAMEA Remifentanil Hydrochloride Sales by Application (2021-2032)
- 12.2.3 SAMEA Remifentanil Hydrochloride Price by Application (2021-2032)
- 12.3 SAMEA Remifentanil Hydrochloride Market Size by Country
- 12.3.1 SAMEA Remifentanil Hydrochloride Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Remifentanil Hydrochloride Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Remifentanil Hydrochloride Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Remifentanil Hydrochloride Value Chain Analysis
- 13.1.1 Remifentanil Hydrochloride Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Remifentanil Hydrochloride Production Mode & Process
- 13.2 Remifentanil Hydrochloride Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Remifentanil Hydrochloride Distributors
- 13.2.3 Remifentanil Hydrochloride Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst